drugset / Trial / NCT00002393
A Study of Indinavir Taken With or Without DMP 266
Parallel-groupTreatment
Summary
The purpose of this study is to see if it is safe and effective to add DMP 266 to an anti-HIV treatment program of indinavir and nucleoside reverse transcriptase inhibitors (NRTIs).
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Efavirenz | Other / unclassified | — | — |
| Background | INDINAVIR ANHYDROUS | Other / unclassified | — | — |